1
|
Panner Selvam MK, Baskaran S, O’Connell S, Almajed W, Hellstrom WJG, Sikka SC. Association between Seminal Oxidation-Reduction Potential and Sperm DNA Fragmentation-A Meta-Analysis. Antioxidants (Basel) 2022; 11:antiox11081563. [PMID: 36009282 PMCID: PMC9404741 DOI: 10.3390/antiox11081563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Revised: 08/09/2022] [Accepted: 08/10/2022] [Indexed: 11/16/2022] Open
Abstract
Seminal oxidative stress and sperm DNA damage are potential etiologies of male factor infertility. The present study aims to evaluate the relationship between oxidation-reduction potential (ORP), a measure of oxidative stress, and sperm DNA fragmentation (SDF) by conducting a systematic review and meta-analysis of relevant clinical data. A literature search was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The COVIDENCE tool was used to screen and identify studies evaluating seminal ORP and SDF. Studies (n = 7) that measured seminal ORP and SDF of 3491 semen samples were included in the analysis. The fixed-effects model revealed a significant pooled correlation coefficient (r = 0.24; p < 0.001) between seminal ORP and SDF. Furthermore, subgroup analyses indicated that the pooled correlation coefficient between ORP and sperm chromatin dispersion (SCD) assay was less than other SDF assays (0.23 vs. 0.29). There was a moderate level of heterogeneity (I2 = 42.27%) among the studies, indicating a lack of publication bias. This is the first meta-analysis to reveal a positive correlation between seminal ORP and SDF. Furthermore, this study indicates the role of oxidative stress in the development of sperm DNA damage and thus warrants prospectively exploring the clinical value of these sperm function tests.
Collapse
Affiliation(s)
- Manesh Kumar Panner Selvam
- Department of Urology, School of Medicine, Tulane University, New Orleans, LA 70112, USA
- Correspondence: (M.K.P.S.); (S.C.S.); Tel.: +1-(504)988-2754 (M.K.P.S.)
| | - Saradha Baskaran
- Department of Urology, School of Medicine, Tulane University, New Orleans, LA 70112, USA
| | - Samantha O’Connell
- Office of Academic Affairs and Provost, Tulane University, New Orleans, LA 70112, USA
| | - Wael Almajed
- Department of Urology, School of Medicine, Tulane University, New Orleans, LA 70112, USA
| | - Wayne J. G. Hellstrom
- Department of Urology, School of Medicine, Tulane University, New Orleans, LA 70112, USA
| | - Suresh C. Sikka
- Department of Urology, School of Medicine, Tulane University, New Orleans, LA 70112, USA
- Correspondence: (M.K.P.S.); (S.C.S.); Tel.: +1-(504)988-2754 (M.K.P.S.)
| |
Collapse
|
2
|
Castleton PE, Deluao JC, Sharkey DJ, McPherson NO. Measuring Reactive Oxygen Species in Semen for Male Preconception Care: A Scientist Perspective. Antioxidants (Basel) 2022; 11:antiox11020264. [PMID: 35204147 PMCID: PMC8868448 DOI: 10.3390/antiox11020264] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2022] [Revised: 01/24/2022] [Accepted: 01/25/2022] [Indexed: 12/04/2022] Open
Abstract
Oxidative stress and elevated levels of seminal and sperm reactive oxygen species (ROS) may contribute to up to 80% of male infertility diagnosis, with sperm ROS concentrations at fertilization important in the development of a healthy fetus and child. The evaluation of ROS in semen seems promising as a potential diagnostic tool for male infertility and male preconception care with a number of clinically available tests on the market (MiOXSYS, luminol chemiluminescence and OxiSperm). While some of these tests show promise for clinical use, discrepancies in documented decision limits and lack of cohort studies/clinical trials assessing their benefits on fertilization rates, embryo development, pregnancy and live birth rates limit their current clinical utility. In this review, we provide an update on the current techniques used for analyzing semen ROS concentrations clinically, the potential to use of ROS research tools for improving clinical ROS detection in sperm and describe why we believe we are likely still a long way away before semen ROS concentrations might become a mainstream preconception diagnostic test in men.
Collapse
Affiliation(s)
- Patience E. Castleton
- Freemasons Centre for Male Health and Wellbeing, The University of Adelaide, Adelaide 5005, Australia; (P.E.C.); (J.C.D.)
- Robinson Research Institute, The University of Adelaide, Adelaide 5005, Australia;
- Adelaide Health and Medical School, School of Biomedicine, Discipline of Reproduction and Development, The University of Adelaide, Adelaide 5005, Australia
| | - Joshua C. Deluao
- Freemasons Centre for Male Health and Wellbeing, The University of Adelaide, Adelaide 5005, Australia; (P.E.C.); (J.C.D.)
- Robinson Research Institute, The University of Adelaide, Adelaide 5005, Australia;
- Adelaide Health and Medical School, School of Biomedicine, Discipline of Reproduction and Development, The University of Adelaide, Adelaide 5005, Australia
| | - David J. Sharkey
- Robinson Research Institute, The University of Adelaide, Adelaide 5005, Australia;
- Adelaide Health and Medical School, School of Biomedicine, Discipline of Reproduction and Development, The University of Adelaide, Adelaide 5005, Australia
| | - Nicole O. McPherson
- Freemasons Centre for Male Health and Wellbeing, The University of Adelaide, Adelaide 5005, Australia; (P.E.C.); (J.C.D.)
- Robinson Research Institute, The University of Adelaide, Adelaide 5005, Australia;
- Adelaide Health and Medical School, School of Biomedicine, Discipline of Reproduction and Development, The University of Adelaide, Adelaide 5005, Australia
- Repromed, 180 Fullarton Rd., Dulwich 5065, Australia
- Correspondence: ; Tel.: +61-8-8313-8201
| |
Collapse
|
3
|
Saliev T, Fakhradiyev I, Tanabayeva S, Assanova Y, Toishybek D, Kazybayeva A, Tanabayev B, Sikhymbaev M, Alimbayeva A, Toishibekov Y. "Radio-Protective Effect of Aminocaproic Acid in Human Spermatozoa". Int J Radiat Biol 2022; 98:1462-1472. [PMID: 35021023 DOI: 10.1080/09553002.2022.2027540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
BACKGROUND The negative effects of ionizing radiation on organs and the reproductive system are well known and documented. Exposure to gamma radiation can lead to oligospermia, azoospermia and DNA damage. Up to date, there is no effective pharmaceutical compound for protecting the male reproductive system and sperm. OBJECTIVE This study aimed at investigating the ability of Ɛ-aminocaproic acid (EACA) to prevent the damage of human spermatozoa and DNA induced by ionizing radiation. MATERIALS AND METHODS Sperm samples were obtained from healthy volunteers (35 men; 31.50 ± 7.34 years old). There were 4 experimental groups: 1) control group (CG), 2) group exposed to maximal radiation dose 67.88 mGy (RMAX), 3) low-dose radiation (minimal) 22.62 mGy (RMIN), and 4) group treated with radiation (67.88 mGy) and EACA (dose 50 ng/ml). Sperm motility, viability, and DNA damage were assessed. RESULTS We observed a significant decrease in total sperm motility of the RMAX group compared to CG (p < 0.05). Sperm viability in the RMAX group was also reduced in comparison to the control (p < 0.05). A significant increase in DNA fragmentation was detected in the RMAX group. The results demonstrated that the treatment of sperm with EACA led to a decrease in the fragmentation of the sperm DNA (compared to the RMAX group) (p < 0.05). CONCLUSION The results indicate that EACA effectively protects human spermatozoa from DNA damage induced by ionizing radiation. Treatment of spermatozoa with EACA led to the preservation of cell motility, viability, and DNA integrity upon radiation exposure.
Collapse
Affiliation(s)
- Timur Saliev
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | - Ildar Fakhradiyev
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | - Shynar Tanabayeva
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | - Yelena Assanova
- F.M. Muhamedgaliev Institute of Experimental Biology, Almaty, Kazakhstan
| | - Dinmukhamed Toishybek
- F.M. Muhamedgaliev Institute of Experimental Biology, Almaty, Kazakhstan.,Embryo Technology Labs, Almaty, Kazakhstan
| | - Aigul Kazybayeva
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.,Clinic of Reproduction and Anti Age, Almaty, Kazakhstan
| | | | - Marat Sikhymbaev
- S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
| | | | - Yerzhan Toishibekov
- F.M. Muhamedgaliev Institute of Experimental Biology, Almaty, Kazakhstan.,Embryo Technology Labs, Almaty, Kazakhstan
| |
Collapse
|
4
|
Toxicity of Antioxidant Supplements in Patients with Male Factor Infertility: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Antioxidants (Basel) 2021; 11:antiox11010089. [PMID: 35052594 PMCID: PMC8772951 DOI: 10.3390/antiox11010089] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2021] [Revised: 12/21/2021] [Accepted: 12/25/2021] [Indexed: 12/28/2022] Open
Abstract
Treating oxidative stress through antioxidant therapy has been considered an appealing strategy in the management of male infertility. However, evidence regarding the toxicity of antioxidant therapy is controversial. We summarized the available clinical evidence on the toxicity associated with the use of antioxidants in infertile males. A systematic review was performed in March 2021. We included randomized controlled trials evaluating the incidence of adverse events in male patients with infertility receiving antioxidant therapy. Thirteen studies involving 1999 male patients were identified. Antioxidant supplementation in patients with male factor infertility was associated with a statistically significantly increased risk of nausea (Odds Ratio: 2.16, 95% Confidence Interval: 1.05–4.43, p = 0.036), headache (Odds Ratio: 3.05, 95% Confidence Interval: 1.59– 5.85 p = 0.001), and dyspepsia (Odds Ratio: 4.12, 95% Confidence Interval: 1.43–11.85, p = 0.009) compared to a placebo. Treatment discontinuation due to adverse events was not significantly higher in patients taking antioxidants compared to a placebo (Odds Ratio: 2.29, 95% Confidence Interval: 0.76–6.88, p = 0.139). When antioxidant supplementation is considered, a more accurate risk/benefit analysis is warranted.
Collapse
|
5
|
Evans EPP, Scholten JTM, Mzyk A, Reyes-San-Martin C, Llumbet AE, Hamoh T, Arts EGJM, Schirhagl R, Cantineau AEP. Male subfertility and oxidative stress. Redox Biol 2021; 46:102071. [PMID: 34340027 PMCID: PMC8342954 DOI: 10.1016/j.redox.2021.102071] [Citation(s) in RCA: 45] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Revised: 07/14/2021] [Accepted: 07/14/2021] [Indexed: 02/08/2023] Open
Abstract
To date 15% of couples are suffering from infertility with 45-50% of males being responsible. With an increase in paternal age as well as various environmental and lifestyle factors worsening these figures are expected to increase. As the so-called free radical theory of infertility suggests, free radicals or reactive oxygen species (ROS) play an essential role in this process. However, ROS also fulfill important functions for instance in sperm maturation. The aim of this review article is to discuss the role reactive oxygen species play in male fertility and how these are influenced by lifestyle, age or disease. We will further discuss how these ROS are measured and how they can be avoided during in-vitro fertilization.
Collapse
Affiliation(s)
- Emily P P Evans
- Department of Biomedical Engineering, Groningen University University Medical Center Groningen, Antonius Deusinglaan 1, 9713AW, Groningen, the Netherlands
| | - Jorien T M Scholten
- Department of Biomedical Engineering, Groningen University University Medical Center Groningen, Antonius Deusinglaan 1, 9713AW, Groningen, the Netherlands
| | - Aldona Mzyk
- Department of Biomedical Engineering, Groningen University University Medical Center Groningen, Antonius Deusinglaan 1, 9713AW, Groningen, the Netherlands; Institute of Metallurgy and Materials Science, Polish Academy of Sciences, Reymonta 25, 30-059, Krakow, Poland
| | - Claudia Reyes-San-Martin
- Department of Biomedical Engineering, Groningen University University Medical Center Groningen, Antonius Deusinglaan 1, 9713AW, Groningen, the Netherlands
| | - Arturo E Llumbet
- Department of Biomedical Engineering, Groningen University University Medical Center Groningen, Antonius Deusinglaan 1, 9713AW, Groningen, the Netherlands; Laboratory of Genomic of Germ Cells, Biomedical Sciences Institute, Faculty of Medicine, University of Chile. Independencia, 1027, Independencia Santiago, Chile
| | - Thamir Hamoh
- Department of Biomedical Engineering, Groningen University University Medical Center Groningen, Antonius Deusinglaan 1, 9713AW, Groningen, the Netherlands
| | - Eus G J M Arts
- Department of Obstetrics and Gynaecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Romana Schirhagl
- Department of Biomedical Engineering, Groningen University University Medical Center Groningen, Antonius Deusinglaan 1, 9713AW, Groningen, the Netherlands.
| | - Astrid E P Cantineau
- Department of Obstetrics and Gynaecology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
| |
Collapse
|